Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Journal of the National Cancer Center|September 16, 2024
CAR-T in cancer therapeutics and updatesShigui ZhuCurrent Allergy and Asthma Reports|August 9, 2003
Immune disorders caused by defects in the caspase cascadeJennifer M Puck, Shigui ZhuJournal of Immunotherapy (Hagerstown, Md. : 1997)|October 24, 2012
Characterization of T-cell receptors directed against HLA-A*01-restricted and C*07-restricted epitopes of MAGE-A3 and MAGE-A12Shigui Zhu, Benoit J Van den Eynde, Pierre G Coulie, et al.Frontiers in Immunology|May 20, 2020
Selection of a Clinical Lead TCR Targeting Alpha-Fetoprotein-Positive Liver Cancer Based on a Balance of Risk and BenefitXiaobing Luo, Huijuan Cui, Lun Cai, et al.American Journal of Hematology|October 1, 2024
C-CAR066, a novel fully human anti-CD20 CAR-T therapy for relapsed or refractory large B-cell lymphoma after failure of anti-CD19 CAR-T therapy: A phase I clinical studyPing Li, Wei Liu, Lili Zhou, et al.Human Genetics|February 1, 2006
Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndromeShigui Zhu, Amy P Hsu, Marla M Vacek, et al.Journal for Immunotherapy of Cancer|September 13, 2022
Phase 1 study of C-CAR088, a novel humanized anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myelomaXiaoyan Qu, Gang An, Weiwei Sui, et al.Pageof 1